- SHRM
appoints former Red Bull Canada president to Special Advisory Committee
- New
member’s background in heavily regulated industries coupled with
experience in CPG space provides great complement
- Effective
immediately, Champignon common shares being traded on OTCQB Venture Market
Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496),
a Canada-based company dedicated to applying novel and natural treatment
protocols with an emphasis on psychedelic medicine, announced the appointment of
Jim Bailey as a new member of its Special Advisory Committee. The appointment
of Bailey, a former president of Red Bull Canada, is designed to strengthen
SHRM’s pharmaceutical, nutraceutical and CPG marketing/distribution
competencies (http://ibn.fm/UjO9v).
“I am very excited to be part of a company that is leading
the way in finding alternative solutions to traditional pharmaceuticals with
science-based research and functional products,” Bailey noted in a news
release. “My background in heavily regulated industries coupled with my
experience in the CPG space provides a great complement to an already talented
and experienced advisory board.”
In his position at Red Bull Canada, Bailey played a key role
in introducing the Red Bull brand in Canada and growing the business to $150
million in annual revenue with more than 300 employees. In addition to his
experience at Red Bull, Bailey served as the global chief marketing office for
Merrell Outdoors, overseeing both product and consumer marketing; during his
tenure, Merrell Outdoors reported annual revenues of up to $600 million.
In his new position on Champignon’s Special Advisory
Committee, Bailey will “champion the marketing, distribution and
commercialization of the company’s Novoformulations-branded novel delivery
systems for the pharmaceutical, nutraceutical and psychedelic medicine
industries,” the company announced.
A wholly owned subsidiary of Champignon, Novoformulations is
focused on working with ketamine, anaesthetics and adaptogenics, along with
other pharmaceuticals and natural molecules at a purpose-built good
manufacturing practice (GMP) and pharmaceutical (DIN) licensed facility located
in Quebec. As part of these efforts, Novoformulations is formulating,
developing and working to commercialize bioavailable transdermal, intranasal
and sublingual delivery platforms.
In addition, Champignon announced that, effective
immediately, its common shares are being traded on the OTCQB Venture Market, a
U.S. trading platform operated by the OTC Markets Group; the shares will be
traded under the ticker ‘SHRMF’ (http://ibn.fm/8mF7O). Champignon’s common shares will
continue to trade on the Canadian Securities Exchange under the ticker symbol
‘SHRM’, as well as on the quotation board of the Frankfurt Stock Exchange under
the ticker symbol ‘496’.
The OTCQB is the foremost exchange for entrepreneurial and
development-stage U.S. and international companies focused on providing
superior experience for U.S. investors. To trade on the market, companies must
be current in their financial reportings, pass a minimum-bid price test, and
undergo an annual company verification and management certification process.
Companies that are approved to trade on the OTCQB exchange have met quality
standards that provide a strong baseline of transparency and are committed to
improving the information and trading experience for investors.
Champignon seeks opportunities to promote the health and wellness
benefits of functional mushrooms, which are used in a wide variety of
health-care and pharmaceutical products. The company’s flagship e-commerce
store, VitalitySuperTeas.com, takes advantage of the burgeoning craft
mushroom industry with a selection of mushroom-infused teas and accessories;
SHRM is also expanding its preclinical trial pipeline and branching out into
alternative medicine and pharmaceuticals.
For more information, visit the company’s website at www.ChampignonBrands.com
NOTE TO INVESTORS: The latest news and updates
relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment